Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 318

1.

Trends and black/white differences in treatment for nonmetastatic prostate cancer.

Klabunde CN, Potosky AL, Harlan LC, Kramer BS.

Med Care. 1998 Sep;36(9):1337-48.

PMID:
9749657
2.

Predictors of aggressive therapy for nonmetastatic prostate carcinoma in Massachusetts from 1998 to 2002.

Rose AJ, Backus BM, Gershman ST, Santos P, Ash AS, Battaglia TA.

Med Care. 2007 May;45(5):440-7.

PMID:
17446830
3.

Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes study.

Hoffman RM, Harlan LC, Klabunde CN, Gilliland FD, Stephenson RA, Hunt WC, Potosky AL.

J Gen Intern Med. 2003 Oct;18(10):845-53.

4.

Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999.

Zeliadt SB, Potosky AL, Etzioni R, Ramsey SD, Penson DF.

Urology. 2004 Dec;64(6):1171-6.

PMID:
15596192
5.

Racial treatment trends in localized/regional prostate carcinoma: 1992-1999.

Underwood W 3rd, Jackson J, Wei JT, Dunn R, Baker E, Demonner S, Wood DP.

Cancer. 2005 Feb 1;103(3):538-45.

6.

Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer.

Shavers VL, Brown M, Klabunde CN, Potosky AL, Davis W, Moul J, Fahey A.

Med Care. 2004 Mar;42(3):239-50.

PMID:
15076823
7.

Prostate cancer stage shift has eliminated the gap in disease-free survival in black and white American men after radical prostatectomy.

Bianco FJ Jr, Wood DP Jr, Grignon DJ, Sakr WA, Pontes JE, Powell IJ.

J Urol. 2002 Aug;168(2):479-82.

PMID:
12131292
8.

Marriage and ethnicity predict treatment in localized prostate carcinoma.

Denberg TD, Beaty BL, Kim FJ, Steiner JF.

Cancer. 2005 May 1;103(9):1819-25.

9.

Prostate specific antigen kinetics at tumor recurrence after radical prostatectomy do not suggest a worse disease prognosis in black men.

Bissonette EA, Fulmer BR, Petroni GR, Moul JW, Theodorescu D.

J Urol. 2001 Oct;166(4):1328-31; discussion 1331-2.

PMID:
11547067
10.
11.

Racial differences in definitive breast cancer therapy in older women: are they explained by the hospitals where patients undergo surgery?

Keating NL, Kouri E, He Y, Weeks JC, Winer EP.

Med Care. 2009 Jul;47(7):765-73. doi: 10.1097/MLR.0b013e31819e1fe7.

PMID:
19536008
12.

Decrease in racial disparities in the staging evaluation for prostate cancer after publication of staging guidelines.

Abraham N, Wan F, Montagnet C, Wong YN, Armstrong K.

J Urol. 2007 Jul;178(1):82-7; discussion 87. Epub 2007 May 11.

PMID:
17499294
13.

Clinical stage T1c prostate cancer: pathologic outcomes following radical prostatectomy in black and white men.

Eastham JA, Carver B, Katz J, Kattan MW.

Prostate. 2002 Mar 1;50(4):236-40.

PMID:
11870801
14.

Racial differences in prostate cancer treatment outcomes: a systematic review.

Peters N, Armstrong K.

Cancer Nurs. 2005 Mar-Apr;28(2):108-18. Review.

PMID:
15815180
15.

Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1).

Schymura MJ, Kahn AR, German RR, Hsieh MC, Cress RD, Finch JL, Fulton JP, Shen T, Stuckart E.

BMC Cancer. 2010 Apr 19;10:152. doi: 10.1186/1471-2407-10-152.

16.

Racial differences in mortality among Medicare recipients after treatment for localized prostate cancer.

Godley PA, Schenck AP, Amamoo MA, Schoenbach VJ, Peacock S, Manning M, Symons M, Talcott JA.

J Natl Cancer Inst. 2003 Nov 19;95(22):1702-10.

17.

Racial/ethnic disparities in the treatment of localized/regional prostate cancer.

Underwood W, De Monner S, Ubel P, Fagerlin A, Sanda MG, Wei JT.

J Urol. 2004 Apr;171(4):1504-7.

PMID:
15017208
18.

Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate.

Harlan L, Brawley O, Pommerenke F, Wali P, Kramer B.

J Clin Oncol. 1995 Jan;13(1):93-100.

PMID:
7799048
19.
20.
Items per page

Supplemental Content

Write to the Help Desk